General Information of the Compound
| Compound ID |
CP0396314
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-cycloheptyl-1-[(4-fluorophenyl)methyl]-2-oxo-4,5-diphenylpyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H31FN2O2
|
||||||||||||||||||
| Molecular Weight |
494.61
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(Cn2cc(-c3ccccc3)c(-c3ccccc3)c(C(=O)NC3CCCCCC3)c2=O)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H31FN2O2/c33-26-19-17-23(18-20-26)21-35-22-28(24-11-5-3-6-12-24)29(25-13-7-4-8-14-25)30(32(35)37)31(36)34-27-15-9-1-2-10-16-27/h3-8,11-14,17-20,22,27H,1-2,9-10,15-16,21H2,(H,34,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
NVXJDTWWJBXSEN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2
Protein ID: PT01099, Fatty-acid amide hydrolase 1
Protein ID: PT06316, Lysophosphatidylserine lipase ABHD12
Protein ID: PT02720, Monoacylglycerol lipase ABHD6
Protein ID: PT01782, Monoglyceride lipase